CAM CAPITAL
CAM Capital manages private family investments. The firm’s goal is to achieve long-term compounded growth of its portfolio using a diversified, opportunistic investment strategy. In pursuit of this goal, CAM Capital engages in both trading activities and fundamentally driven investments. Our investments span all parts of the corporate capital structure in both the private and public markets. ###Caxton Alternative Management announced that it is changing its name to CAM Capital.###
CAM CAPITAL
Social Links:
Industry:
Financial Services Hedge Funds
Founded:
2012-01-01
Status:
Active
Contact:
+1 212 205 6800
Email Addresses:
[email protected]
Total Funding:
1.63 M USD
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Azure DNS DigiCert SSL GlobalSign Domain Verification WebEx Imperva Bot Detection And Mitigation Incapsula Cisco Ironport Cloud
Similar Organizations
Green Mesa Capital
Green Mesa Capital specializes in traditional and alternative investments.
Point72
Point72 invests in multiple asset classes and strategies worldwide.
Three Arrows Capital
Three Arrows Capital is a hedge fund manager that provides risk-adjusted returns.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-16 | Kriya Therapeutics | CAM Capital investment in Series C - Kriya Therapeutics | 270 M USD |
| 2022-01-26 | Kyverna Therapeutics | CAM Capital investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2022-01-05 | AvengeBio | CAM Capital investment in Series A - AvengeBio | 45 M USD |
| 2021-11-03 | Antios Therapeutics | CAM Capital investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-09-09 | LEXEO Therapeutics | CAM Capital investment in Series B - LEXEO Therapeutics | 100 M USD |
| 2021-07-14 | Kriya Therapeutics | CAM Capital investment in Series B - Kriya Therapeutics | 100 M USD |
| 2021-04-15 | AltruBio | CAM Capital investment in Series A - AltruBio | 63 M USD |
| 2021-04-13 | Arcellx | CAM Capital investment in Series C - Arcellx | N/A |
| 2021-04-12 | Antios Therapeutics | CAM Capital investment in Series B - Antios Therapeutics | 96 M USD |
| 2020-10-27 | Primmune Therapeutics | CAM Capital investment in Series A - Primmune Therapeutics | 27.4 M USD |